215
Views
32
CrossRef citations to date
0
Altmetric
Review

Applications of biomimetic systems in drug delivery

, , &
Pages 1085-1096 | Published online: 04 Nov 2005

Bibliography

  • LANGER R, PEPPAS NA: Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J. (2003) 49(12)2990–3006.
  • ••Thorough review of the literature on thesubject with critical analysis of expectations.
  • SANCHEZ C, ARRIBART H, MADELEINE M, GUILLE G: Biomimetism and bioinspiration as tools for the design of innovative materials and systems. Nat. Mat. (2005) 4(4):277–288.
  • ••Excellent review covering various aspects ofthe biomimetic field.
  • SARIKAYA M: Biomimetics: materials fabrication through biology. Proc. Natl. Acad. Sci. USA (1999) 96(25):14183–14185.
  • SARIKAYA M, TAMERLER C, JEN AK, SCHULTEN K, BANEYX F: Molecular biomimetics: nanotechnology through biology. Nat. Mat. (2003) 2(9):577–585.
  • SEEMAN NC, BELCHER AM: Emulating biology: building nanostructures from the bottom up. Proc. Nati Acad. Sci. USA (2002) 99(9 Suppl. 2):6451–6455.
  • SHIN H, JO S, MIKOS AG: Biomimetic materials for tissue engineering. Biomaterials (2003) 24(24):4353–4364.
  • ••A seminal contribution towardsidentification of the important properties of biomimetic scaffolds.
  • TU RS, TIRRELL M: Bottom-up design of biomimetic assemblies. Adv. Drug Delivery Rev (2004) 56(11):1537–1563.
  • ZHANG S: Fabrication of novel biomaterials through molecular self-assembly. Nat. Biotechnol (2003) 21(10):1171–1178.
  • ••Excellent review covering various aspects ofthe biomimetic field.
  • ALIVISATOS AP, JOHNSSON KP, PENG X etal: Organization of hanocrystal molecules' using DNA. Nature (1996) 382(6592):609–611.
  • ••Seminal contribution on nanocrystalstructure.
  • CHEN J, SEEMAN NC: Synthesis from DNA of a molecule with the connectivity of a cube. Nature (1991) 350(6319):631–633.
  • MIRKIN CA, LETSINGER RL, MUCIC RC, STORHOFF JJ: A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature (1996) 382(6592):607–609.
  • ••This and [9] were published back-to-backin the same issue and were the first reports demonstrating nanoparticle assembly using oligonucleotide base pairing rules.
  • GHADIRI MR, GRANJA JR, BUEHLER LK: Artificial transmembrane ion channels from self-assembling peptide nanotubes. Nature (1994) 369(6478)301–304.
  • GHADIRI MR, GRANJA JR, MILLIGAN RA, MCREE DE, KHAZANOVICH N: Self-assembling organic nanotubes based on a cyclic peptide architecture. Nature (1993) 366(6453):324–327.
  • FERNANDEZ-LOPEZ S, KIM H- CHOI EC et al.: Antibacterial agents based on the cyclic 0,1,-a-peptide architecture. Nature (2001) 412(6845):452–456.
  • SANCHEZ-QUESADA J, ISLER MP, GHADIRI MR: Modulating ion channel properties of transmembrane peptide nanotubes through heteromeric supramolecular assemblies. Am. Chem. Soc. (2002) 124(34):l0004–l0005.
  • SILVA GA: Introduction to nanotechnology and its applications to medicine. Surg. Neurol (2004) 61(3):216–220.
  • SILVA GA, CZEISLER C, NIECE KL et al.: Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science (2004) 303(5662):1352–1355.
  • PEPPAS NA, HUANG YB: Nanoscale technology of mucoadhesive interactions. Adv. Drug Delivery Rev. (2004) 56(11):1675–1687.
  • PEPPAS NA, HUANG Y: Polymers and gels as molecular recognition agents. Pharm. Res. (2002) 19(5):578–587.
  • BIES C, LEHR C, WOODLEY JF: Lectin-mediated drug targeting: history and applications. Adv. Drug Delivery Rev. (2004) 56:425–435.
  • HAAS J, LEHR CM: Developments in the area of bioadhesive drug delivery systems. Exp. Opin. Biol. Therapy (2002) 2(3):287–298.
  • SMART JD: Recent developments in the use of bioadhesive systems for delivery of drugs to the oral cavity. Grit. Rev. Ther. Drug Carrier Syst. (2004) 21(4):319–344.
  • HAMMER DA, TIRRELL M: Biological adhesion at interfaces. Ann. Rev Mat. Sci. (1996) 26:651–691.
  • TIRRELL M, KOKKOLI E, BIESALSKI M: The role of surface science in bioengineered materials. Surf Sci. (2002) 500(1-3):61–83.
  • ••A pioneering contribution in the field ofsurface science of biomaterials.
  • YU Y- BERNDT P, TIRRELL M, FIELDS GB: Self-assembling amphiphiles for construction of protein molecular architecture. J. Am. Chem. Soc. (1996) 118(50):12515–12520.
  • WU AM, TAN GJ, SHERMAN MA et al.: Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange. Protein Eng. (2001) 14(12):1025–1033.
  • LI L, OLAFSEN T, ANDERSON AL et al: Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody. Bioconjug. Chem. (2002) 13(5):985–995.
  • GIL ES, HUDSON SM: Stimuli-reponsive polymers and their bioconjugates. Progress Poly Sci. (2004) 29(12):1173.
  • DROTLEFF S, LUNGWITZ U, BREUNIG M et al: Biomimetic polymers in pharmaceutical and biomedical sciences. Eur. j Pharm. Biopharm. (2004) 58(2)385–407.
  • DONG C- FAUCHER KM, CHAIKOF EL: Synthesis and properties of biomimetic poly(Lrglutamate)-b-poly(2-acryloyloxyethyllactoside)-b-poly(Lr glutamate) triblock copolymers. J. Polym. Sci. Part A: Polym. Chem. (2004) 42 (22) :5754–5765.
  • ••Uses calmodulin for conformation switches.
  • LACKEY CA, PRESS OW, HOFFMAN AS, STAYTON PS: A biomimetic pH-responsive polymer directs endosomal release and intracellular delivery of an endocytosed antibody complex. Biocorgug. Chem. (2002) 13(5):996–1001.
  • ••One of the pioneering papers onbiomimetic chemistry and endosomal release.
  • WANG C, STEWART RJ, KOPECEK J: Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature (1999) 397(6718):417–420.
  • ••Uses the leucine zipper domain.
  • EHRICK JD, DEO SK, BROWNING TW et al.: Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics. Nat. Mat. (2005) 4(4):298–302.
  • PETKA WA, HARDIN JL, MCGRATH KP, WIRTZ D, TIRRELL DA: Reversible hydrogels from self-assembling artificial proteins. Science (1998) 281(5375):389–392.
  • ••Uses the leucine zipper domain.
  • CHOI Y, THOMAS T, KOTLYAR A, ISLAM MT, BAKER JR Jr: Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem. Biol. (2005) 12(1):35–43.
  • ELLINGTON AD, SZOSTAK JW: In vitro selection of RNA molecules that bind specific ligands. Nature (1990) 346(6287):818–822.
  • ••Groundbreaking paper that helped openthe door to the widespread application of aptamers.
  • TUERK C, GOLD L: Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (1990) 249:505–510.
  • ••Groundbreaking paper that helped openthe door to the widespread application of aptamers.
  • NIMJEE SM, RUSCONI CP, SULLENGER BA: Aptamers: an emerging class of therapeutics. Ann. Rev Med. (2005) 56:555–583.
  • EATON BE: The joys of in vitro selection:chemically dressing oligonucleotides to satiate protein targets. Curr. Opin. Chem. Bio. (1997) 1(1):10–16.
  • HERMANN T, PATEL DJ: Adaptive recognition by nucleic acid aptamers. Science (2000) 287(5454):820–825.
  • HAMAGUCHI N, ELLINGTON A, STANTON M: Aptamer beacons for the direct detection of proteins. Anal. Biochem. (2001) 294(2):126–131.
  • JHAVERI S, RAJENDRAN M, ELLINGTON AD: LI vitro selection of signaling aptamers. Nat. Biotech. (2000) 18(12):1293–1297.
  • MONERA OD, KAY CM, HODGES RS: Electrostatic interactions control the parallel and antiparallel orientation of alpha-helical chains in two-stranded alpha-helical coiled-coils. Biochemistry (1994) 33(13):3862–3871.
  • SU JY, HODGES RS, KAY CM: Effect of chain length on the formation and stability of synthetic alpha-helical coiled coils. Biochemistry (1994) 33(51):15501–15510.
  • ••Two classic papers by the leading group ina-helical coiled-coil chemistry.
  • TRIPET B, YU L, BAUTISTA DL et al: Engineering a de novo-designed coiled-coil heterodimerization domain off the rapid detection, purification and characterization of recombinantly expressed peptides and proteins. Protein Eng. (1996) 9(10:1029–1042.
  • WAGSCHAL K, TRIPET B, HODGES RS: De novo design of a model peptide sequence to examine the effects of single amino acid substitutions in the hydrophobic core on both stability and oligomerization state of coiled-coils. Mol. Biol. (1999) 285(2):785–803.
  • KOHN WD, KAY CM, HODGES RS: Orientation, positional, additivity, and oligomerization-state effects of interhelical ion pairs in alpha-helical coiled-coils. J. Mol. Biol. (1998) 283(5):993–1012.
  • ZHOU NE, KAY CM, HODGES RS: The role of interhelical ionic interactions in controlling protein folding and stability. De novo designed synthetic two-stranded alpha-helical coiled-coils. J. Mol. Biol. (1994) 237(4):500–512.
  • ZHOU NE, KAY CM, HODGES RS: Synthetic model proteins. Positional effects of interchain hydrophobic interactions on stability of two-stranded alpha-helical coiled-coils. J. Biol. Chem. (1992) 267(4):2664–2670.
  • ZHOU NE, ZHU BY, KAY CM, HODGES RS: The two-stranded alpha-helical coiled-coil is an ideal model for studying protein stability and subunit interactions. Biopolymers (1992) 32(4):419–426.
  • WEISSENHORN W, DESSEN A, HARRISON SC, SKEHEL JJ, WILEY DC: Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 387(6631):426–430.
  • KIM C- QUARSTEN H, BERGSENG E, KHOSLA C, SOLLID LM: Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl. Acad. Sci. USA (2004) 101(12):4175–4179.
  • CRESCENZO G, LITOWSKI JR, HODGES RS, O'CONNOR-MCCOURT MD: Real-time monitoring of the interactions of two-stranded de novo designed coiled-coils: effect of chain length on the kinetic and thermodynamic constants of binding. Biochemistry (2003) 42(6):1754–1763.
  • ARNDT KM, MULLER KM, PLUCKTHUN A: Helix-stabilized Fy (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain. J. Mol. Biol. (2001) 312(1):221–228.
  • PEPPAS NA: Devices based on intelligent biopolymers for oral protein delivery. Intern. J.Pharm. (2004) 277:11–17.
  • PEPPAS NA, WOOD KM, BLANCHETTE JO: Hydrogels for oral delivery of therapeutic proteins. Expert Opin. Biol. Ther. (2004) 4:881–887.
  • SELLERGREN B: Noncovalent molecular imprinting: antibody-like molecular recognition in polymeric network materials. Trends Anal Chem. (1997) 16(6):310–320.
  • WULFF G: Molecular imprinting in crosslinked materials with the aid of molecular templates - a way towards artificial antibodies. Ang. Che. bit. Edi. (1995) 34(17):1812–1832.
  • BYRNE M, PARK K, PEPPAS NA: Molecular imprinting within hydrogels. Adv. Drug Deily. Revs. (2002) 54:149–161.
  • ••The earliest review on the use of hydrogels In biomedical imprinting
  • BYRNE ME, HENTHORN DB, HUANG Y, PEPPAS NA: Micropatterning biomimetic materials for bioadhesion and drug delivery. In: Biomimetic Materials and Design: Biointerfacial Strategies, Tissue Engineering, and Targeted Drug AK Dillow and A Lowman (Eds), Marcel Dekker, New York, NY, USA (2002):443–470.
  • BYRNE ME, ORAL E, HILT JZ, PEPPAS NA: Networks for recognition of biomolecules: molecular imprinting and micropatterning poly(ethylene glycofi-containing films. Polym. Adv. Technol (2002) 13:798–816.
  • ORAL E, PEPPAS NA: Responsive and recognitive hydrogels using star polymers. Biomed. Mater Res. (2004) 68A:439–447.
  • HILT JZ, MARK E: Configurational biomimesis in drug delivery: molecular imprinting of biologically significant molecules. Adv. Drug Deify. Rev (2004) 56(11):1599–1620.
  • ••A comprehensive review of macromolecular recognition of biologically significant molecules.
  • DISCHER BM, BERMUDEZ H, HAMMER DA et al: Cross-linked polymersome membranes: vesicles with broadly adjustable properties. .1. Phy. Che. B (2002) 106(11):2848–2854.
  • DISCHER BM, WON YY, EGE DS et al: Polymersomes: tough vesicles made from diblock copolymers. Science (1999) 284(5417):1143–1146.
  • BERMUDEZ H, BRANNAN AK, HAMMER DA, BATES FS, DISCHER DE: Molecular weight dependence of polymersome membrane structure, elasticity, and stability. Macromolecules (2002) 35(21):8203–8208.
  • DEMING TJ: Facile synthesis of block copolypeptides of defined architecture. Nature (1997) 390(6658):386–389.
  • ••An excellent reference on the controlledsynthesis of amino acid-based polymeric systems using transition metal catalysts.
  • NOWAK AP, VELD V, PAKSTIS L et al: Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature (2002) 417(6887):424–428.
  • SAVIC R, LUO L, EISENBERG A, MAYSINGER D: Micellar nanocontainers distribute to defined cytoplasmic organelles. Science (2003) 300(5619):615–618.
  • ••Demonstrates the feasibility of liposomesfor hydrophobic drug delivery.
  • LUO L, TAM J, MAYSINGER D, EISENBERG A: Cellular internalization of poly(ethylene oxide)-b-poly(e-caprolactone) diblock copolymer micelles. Bioconjug. Chem. (2002) 13(6):1259–1265.
  • ••Demonstrates the feasibility of liposomesfor hydrophobic drug delivery.
  • PEPPAS N, BURES P, LEOBANDUNG W, ICHIKAWA H: Hydrogels in pharmaceutical formulations. Eur.j Pharm. Biopharm. (2000) 50:27–46.
  • ••A highly cited and leading review in thefield highlighting application, characterisation and drug release from hydrogels.
  • LANGER R: Drug delivery and targeting. Nature (1998) 392:5–10.
  • HENRY C: Special delivery: alternative methods for delivering drugs improve performance, convenience, and patient compliance. C &EN (2000) :49–65.
  • GERSHON D: Microarray technology an array of opportunities. Nature (2002) 416:885–891.
  • KONONEN J, BUBENDORF L, KALLIONIEMI A et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. (1998) 4:844–847.
  • GENOME PROGRAM, US DEPARTMENT OF ENERGY: Human Cenome News (2000) 11(1-2):7.
  • SENTER PD, KOPECEK J: Drug carriersin medicine and biology. Mol. Pharmaceutics (2004) 1(6):395–398.
  • LAVAN DA, MCGUIRE T, LANGER R: Small-scale systems for in vivo drug delivery. Nat. Biotechnol (2003) 21(10):1184–1191.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.